Las Vegas Sun

Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology

Foundation Medicine, Inc., a global precision medicine company, today announced the launch of its Whole Genome Sequencing (WGS) Germline test for research use. This important portfolio expansion is ...
Forbes

A Vision Of AI-Enhanced Test Automation

The complexity of software architecture and diverse user interactions presents challenges to conventional testing approaches. Traditional test automation and quality assurance engineering represented ...
Yahoo Finance

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide

SAN DIEGO, February 05, 2026--(BUSINESS WIRE)--Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat ® KMT2A + MRD ...
Healio

Precision testing strategy strongly benefits stable patients with suspected CAD

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% ...
Labroots

Precision in Practice: Managing Indeterminate TB Testing with Quality Systems

QuantiFERON(R) TB Gold is a test used to diagnose tuberculosis (TB) infection by measuring interferon-gamma release. Test results are reported as: positive, negative, or indeterminate. The American ...
MarketWatch

Invivoscribe(R) Launches LeukoStrat(R) KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat(R) KMT2A + MRD Assay and Software to its industry-leading ...